CareDx, Inc. (CDNA)
72.09
+0.17
(+0.24%)
USD |
NASDAQ |
Nov 20, 10:10
CareDx Cash from Operations (Quarterly) : 12.72M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 12.72M |
| June 30, 2026 | 30.60M |
| March 31, 2026 | 4.333M |
| December 31, 2025 | 21.36M |
| September 30, 2025 | 37.36M |
| June 30, 2025 | 9.895M |
| March 31, 2025 | -26.58M |
| December 31, 2024 | 21.89M |
| September 30, 2024 | 12.52M |
| June 30, 2024 | 18.95M |
| March 31, 2024 | -15.31M |
| December 31, 2023 | -8.381M |
| September 30, 2023 | -10.18M |
| June 30, 2023 | -0.499M |
| March 31, 2023 | 0.671M |
| December 31, 2022 | 7.185M |
| September 30, 2022 | -7.079M |
| June 30, 2022 | -3.877M |
| March 31, 2022 | -21.47M |
| December 31, 2021 | 4.166M |
| September 30, 2021 | 0.382M |
| June 30, 2021 | 9.788M |
| March 31, 2021 | -33.63M |
| December 31, 2020 | 7.181M |
| September 30, 2020 | 5.207M |
| Date | Value |
|---|---|
| June 30, 2020 | 24.10M |
| March 31, 2020 | -3.055M |
| December 31, 2019 | -1.083M |
| September 30, 2019 | 0.605M |
| June 30, 2019 | 3.576M |
| March 31, 2019 | -5.867M |
| December 31, 2018 | 1.998M |
| September 30, 2018 | 0.399M |
| June 30, 2018 | -1.886M |
| March 31, 2018 | -4.518M |
| December 31, 2017 | -2.148M |
| September 30, 2017 | -2.222M |
| June 30, 2017 | -3.196M |
| March 31, 2017 | -6.741M |
| December 31, 2016 | -3.061M |
| September 30, 2016 | -1.203M |
| June 30, 2016 | -6.067M |
| March 31, 2016 | -6.192M |
| December 31, 2015 | -3.976M |
| September 30, 2015 | -3.029M |
| June 30, 2015 | -1.733M |
| March 31, 2015 | -1.014M |
| December 31, 2014 | -0.722M |
| September 30, 2014 | -3.661M |
| June 30, 2014 | 0.853M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Natera, Inc. | 43.93M |
| Myriad Genetics, Inc. | -6.50M |
| BioRestorative Therapies, Inc. | -3.808M |
| Exagen, Inc. | -2.575M |
| Sera Prognostics, Inc. | -7.298M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -147.88M |
| Cash from Financing (Quarterly) | 12.90M |
| Free Cash Flow | 59.76M |
| Free Cash Flow Per Share (Quarterly) | 0.2019 |
| Free Cash Flow to Equity (Quarterly) | 1.349M |
| Free Cash Flow to Firm (Quarterly) | 11.10M |
| Free Cash Flow Yield | 1.58% |